Amir Abolfathi is an experienced innovator and medical device executive. He was a founding team member of uLab Systems, Tusker Medical (acquired by Smith and Nephew) and Sonitus Medical. Amir also served for six years as an Officer, Vice President of R&D at Align Technology Inc. (NASDAQ: ALGN), creators of a unique, invisible orthodontic product. Previously, Amir was the first member of the senior management team at Embolic Protection Inc. (acquired by Boston Scientific), where he was a consulting VP of Operations. In early 1995, Amir co-founded EndoTex Interventional Systems (acquired by Boston Scientific), developers of minimally invasive solutions for treatment of carotid artery disease. Amir has also held various management and engineering positions at Pfizer, Guidant, and Baxter-Edwards. Amir has 150+ patents. He received his M.S. in Engineering Management from the University of Southern California and a B.S. in Biomedical Engineering from UC San Diego.